-
Eli Lilly Announces Guidance, U.S. Insulin Release
Thursday, December 15, 2016 - 9:55am | 488Read More...Shares of Eli Lilly and Co (NYSE: LLY) gained more than 3 percent ahead of Thursday's market open after the company provided the investment community with its financial guidance and an update to a new insulin product. Financial Guidance Eli Lilly guided its full year fiscal 2016 earnings...
-
Eli Lilly Shares Lower Following Weaker-Than-Expected 2016 Guidance
Tuesday, January 5, 2016 - 9:13am | 188Read More...Shares of Eli Lilly and Co (NYSE: LLY) were trading lower by more than 1 percent at $81.78 early Tuesday morning after the company reported a weaker-than-expected fiscal 2016 guidance. Eli Lilly said it expects to earn $3.45 to $3.55 per share in fiscal 2016 on revenue of $20.2 billion to $20.7...
-
Eli Lilly CFO: Solid Underlying Performance Despite FX Headwind
Friday, April 24, 2015 - 1:19pm | 353Read More...Eli Lilly and Co (NYSE: LLY) came out with mixed first-quarter earnings Thursday. EPS for the company, excluding items, came at $0.50 versus $0.67 reported for the same quarter last year. Derica Rice, Eli Lilly CFO, was on CNBC recently to weigh in on the earnings. Solid Underlying...
